Pubmed: Chimeric antigen T cells

Pubmed: Bispecific antibodies & BiTE

GEN Highlights

• An error occurred while fetching this feed: https://www.genengnews.com/gen.rss

Fiercebiotech News

• FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute (2026/07/29 17:51)

  A panel of experts today voted against Capricor’s cell therapy for Duchenne muscular dystrophy, capping off an advisory committee meeting marked by statistical confusion.
• Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination (2026/07/29 13:59)

  After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before quietly scrubbing the evidence.
• ‘Low tech’ chemotherapy nanoparticles show promise for deadly brain tumor recurrence (2026/07/29 11:57)

  A standard chemotherapy drug loaded in nanoparticles has been able to penetrate the blood-brain barrier when administered shortly after resection of the tumor, new research has suggested.
• ‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while (2026/07/29 10:52)

  Biogen's business development team may have been busy in recent years, but CEO Christopher Viehbacher is easing off the acquisitions for a while.
• Novo Nordisk fails to dismiss lawsuit over CagriSema readout (2026/07/29 10:30)

  Novo Nordisk’s attempt to dismiss a lawsuit about its CagriSema readout has failed, with the judge ruling that parts of the investors’ argument were strong enough for the case to proceed.
• Processa acquires Vidya for potential BTK inhibitor rival to Novartis’ Rhapsido (2026/07/29 10:12)

  Processa Pharmaceuticals has made a push into the autoimmune space via the acquisition of Vidya Therapeutics, which delivers a potential rival to Novartis’ Rhapsido.
• ‘Reverse mergers are increasingly popular’: Caldera hops on Synlogic’s Nasdaq listing (2026/07/29 08:56)

  Caldera Therapeutics has struck a reverse merger with the publicly traded Synlogic and inked a $278 million financing deal, continuing the meteoric rise of the inflammatory bowel disease startup.
• Vertex’s latest autoimmune TCE play involves $28M upfront to AbCellera (2026/07/29 08:09)

  AbCellera’s T-cell engager platform has reeled in a second client this summer, with Vertex paying $28 million upfront for a collaboration that will include autoimmune conditions.
• Eli Lilly tops new biopharma ranking on launch success, development speed (2026/07/28 13:02)

  Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural Pipeline-to-Patient Productivity Index, which evaluated 25 large, global biopharma companies on R&D productivity, market access and commercial performance.
• Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options (2026/07/28 10:33)

  Incyte has ditched a JAK2 inhibitor in phase 1 development for a rare blood cancer in favor of “next-generation” replacements.

Google News:Health

• The Best Morning Drink for Hydration, According to Dietitians - EatingWell

  The Best Morning Drink for Hydration, According to Dietitians  EatingWellSee more headlines & perspectives on Google News
• Study links heavy TV watching to brain changes tied to Alzheimer’s - FourStatesHomepage.com

  Study links heavy TV watching to brain changes tied to Alzheimer’s  FourStatesHomepage.comSee more headlines & perspectives on Google News
• ODH, Hamilton County report different cyclosporiasis case numbers - Cincinnati Enquirer

  ODH, Hamilton County report different cyclosporiasis case numbers  Cincinnati Enquirer109 confirmed cases of cyclosporiasis in Northeast Michigan, Tuesday  The Alpena News -Lucas County sees 10 new cases of cyclosporiasis while Michigan surpasses 10,000  Toledo BladeCyclosporiasis cases rise in northwest Ohio, Michigan; Fulton County high among region  WTOL96 new cyclosporiasis reported in northwest Ohio  Toledo Blade
• 9 Things Experts Wish You’d Do in Midlife to Increase Longevity - The New York Times

  9 Things Experts Wish You’d Do in Midlife to Increase Longevity  The New York TimesThe secret to aging well isn’t a supplement: It’s these daily habits  bizjournals.com10 Daily Habits That Help You Stay Younger Longer  yahoo.com5 anti-aging habits to start in your 30s  Leader PublicationsThe Secret of Healthy Aging is Not as Big a Secret as You Might Think  AMAC — The Association of Mature American Citizens
• New cholesterol treatment could be 'game changer' for Spokane, says MultiCare cardiologist - The Spokesman-Review

  New cholesterol treatment could be 'game changer' for Spokane, says MultiCare cardiologist  The Spokesman-ReviewNew Twice-Yearly Inclisiran Therapy Shows Major Reduction in LDL Cholesterol  MedscapeHealth Beat: Clinical studies on Lipfendra pill show success in high-cholesterol patients  wfmz.comNew, more efficient pill to lower cholesterol  The StarFDA approves oral drug meant to help reduce LDL cholesterol  NorthcentralPA.com
• What’s That? Metabolic Disorders Driving Hearing Loss - Medscape

  What’s That? Metabolic Disorders Driving Hearing Loss  Medscape
• Trump's Latest Name For GLP-1s Has Doctors And Patients Raising An Important Concern - HuffPost

  Trump's Latest Name For GLP-1s Has Doctors And Patients Raising An Important Concern  HuffPost
• Cyclosporiasis sickens some people worse – why your diarrhea could be more explosive than others - The Conversation

  Cyclosporiasis sickens some people worse – why your diarrhea could be more explosive than others  The Conversation6,000 sick in parasite outbreak. What doctors say helps severe diarrhea  USA TodayGrocery Shopping in the Age of Explosive Diarrhea  The New YorkerAsk UConn Extension: What to Know About Cyclospora  today.uconn.eduThe Team at Advance ER Shares What You Need to Know About the Cyclosporiasis Outbreak  Morningstar
• Good diet matters more than how processed food is, study suggests - The Times

  Good diet matters more than how processed food is, study suggests  The TimesOpinion | This Teen Took on a $10 Trillion Industry. We Might All Be Healthier Because of Him.  The New York TimesFor long-term health, diet quality matters more than food processing level  EurekAlert!Your Overall Diet May Matter More Than Whether Foods Are Ultra-Processed  Health: Trusted and Empathetic Health and Wellness InformationHow ultra-processed foods may damage your long-term brain health  New Scientist
• Can we stop AI from flooding scientific journals? - C&EN

  Can we stop AI from flooding scientific journals?  C&EN
• Ebola cases in Congo top 3,200, nearing record of the country’s worst outbreak - AP News

  Ebola cases in Congo top 3,200, nearing record of the country’s worst outbreak  AP NewsA day in the life of Congo's overstretched Ebola surveillance teams  ReutersThe fastest growing Ebola outbreak is worsening hunger in eastern Congo, a UN agency chief warns  AP NewsEbola cases in Congo top 3,200, nearing record of the country's worst outbreak  ABC News - Breaking News, Latest News and VideosEBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo | Uganda Weekly External Situation Report 11, Data as of 26 July 2026  WHO | Regional Office for Africa
• Common Supplement Linked to Better Health in Study of 16,000 Older Adults - Newsweek

  Common Supplement Linked to Better Health in Study of 16,000 Older Adults  NewsweekCould a Multivitamin Help You Age Better? Study Suggests Yes  Yahoo HealthA 3-Year Trial Found This Daily Supplement Supports Heart Health  MindBodyGreenDaily multivitamin may help older adults stay independent  ScienceDailyDaily Multivitamin May Help Older Adults Maintain Cardiovascular Function  Inside Precision Medicine
• Older Adults Advised to Limit Anticholinergic Medicines - Medscape

  Older Adults Advised to Limit Anticholinergic Medicines  Medscape
• Josh Shapiro repeals HIV law that made a diagnosis a felony enhancement in Pennsylvania - yahoo.com

  Josh Shapiro repeals HIV law that made a diagnosis a felony enhancement in Pennsylvania  yahoo.comSee more headlines & perspectives on Google News
• Scientists expected one Alzheimer’s advantage in SuperAgers. They were wrong - Newsweek

  Scientists expected one Alzheimer’s advantage in SuperAgers. They were wrong  NewsweekSuperAgers retain exceptional memory through mechanisms beyond genetics  News-MedicalSuperagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds  MedPage TodaySuperagers keep youthful memories but their DNA does not explain why  ScienceDailyMemory Without the Genetic Head Start, a Fiber Fix for Achy Knees, and Why Your Calorie App Is Lying to You  AGEIST
• 14 Healthy Breakfast Foods That Keep You Full for Hours, According to Dietitians - Real Simple

  14 Healthy Breakfast Foods That Keep You Full for Hours, According to Dietitians  Real SimpleHealthy breakfast ideas to support energy and metabolism  Harvard HealthDietitians Suggest These 10 High-Protein Breakfasts That Keep You Satisfied and Energized Throughout the Day  PreventionBest Indian breakfast to control your blood sugar: Don’t like oats? Here’s what diabetes specialist Dr V Mohan recommends  The Times of India5 high-protein breakfast recipes to eat on repeat for fat loss, shared by a fitness coach  Moneycontrol.com
• 2026 cholesterol guidelines: Why 1 in 3 adults are above safe limits - Medical News Today

  2026 cholesterol guidelines: Why 1 in 3 adults are above safe limits  Medical News TodayNew US guidelines may affect how young adults manage ‘bad’ cholesterol  CNNMore than half of U.S. adults now qualify for statins under new guidelines  Michigan MedicineNew Guideline Will Shift Statins to Younger and Lower-Risk U.S. Adults  MedPage TodayIs your cholesterol too high based on latest guidelines?  news.harvard.edu
• Father's diet before conception impacts baby's body composition - News-Medical

  Father's diet before conception impacts baby's body composition  News-Medical
• Researcher Faces Investigation for Concealing 6-Year-Old Girl’s Death in Gene-Editing Trial - Gizmodo

  Researcher Faces Investigation for Concealing 6-Year-Old Girl’s Death in Gene-Editing Trial  Gizmodo6-year-old girl dies after parents paid $860K for experimental therapy that ‘shouldn’t have gone to trial’  New York PostChina biotech sector fears policy backlash after girl dies in gene-editing trial  South China Morning PostExclusive: A couple paid more than $800,000 for a gene-editing therapy for their daughter. She died, and it wasn’t made public  Retraction WatchScandal Exposes Limits of China’s Scientific Rise  Foreign Policy
• Study identifies which bacteria trigger the 'farm effect' that makes children less prone to allergies - Medical Xpress

  Study identifies which bacteria trigger the 'farm effect' that makes children less prone to allergies  Medical Xpress